| Health / Medical Topics |
Human Papillomavirus Tumor Antigen Vaccine
A vaccinia viral based vaccine, encoding epitopes of E6 and E7 proteins from human papillomavirus (HPV) types 16 and 18, with immunostimulatory and antineoplastic activities. HPV types 16 and 18 account for approximately 70% of cervical cancers. Vaccination with this HPV-TA (tumor antigen) vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for E6 and E7 from either type 16 or 18 HPV, resulting in decreased tumor growth. (NCI Thesaurus)
YOU MAY ALSO LIKE
A laboratory test in which cells are tested for DNA or RNA from certain types of human papillomavirus (HPV) that are known…
A laboratory test in which cells are scraped from the cervix to look for RNA of the most common types of human…
A squamous cell carcinoma associated with human papilloma type 16 virus, arising from the oropharynx.
A laboratory test in which cells are scraped from the cervix to look for DNA of human papillomaviruses (HPV). HPV can cause…
A recombinant, bivalent, human papillomavirus (HPV) vaccine, containing virus-like particles for HPV types 16 and 18 linked to the adjuvant ASO4, with…
A synthetic agent derived from human papillomavirus (HPV) E7 nuclear protein which is used to produce vaccines against HPV infection and HPV-related…
